Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 6/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.31 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9412428 | 0.89 | CYP2D6 (0.33) | SLC6A2SLC6A4SLC6A3CYP2D6ROCK2 | |
| SCHEMBL5330905 | 0.76 | SLC6A2 (0.47) | SLC6A2SLC6A4SLC6A3CYP2D6ROCK2 | |
| SCHEMBL29024014 | 0.76 | KDM4E (0.38) | SLC6A2SLC6A4SLC6A3CYP2D6ROCK2 | |
| SCHEMBL9443686 | 0.76 | KDM4E (0.38) | SLC6A2SLC6A4SLC6A3CYP2D6ROCK2 | |
| SCHEMBL7543302 | 0.75 | KDM4E (0.39) | SLC6A2SLC6A4SLC6A3CYP2D6ROCK2 | |
| SCHEMBL8983628 | 0.72 | SLC6A2 (0.49) | SLC6A2SLC6A4SLC6A3CYP2D6ROCK2 | |
| SCHEMBL5666455 | 0.71 | SLC6A2 (0.37) | SLC6A2SLC6A4SLC6A3CYP2D6CHRNA7 | |
| Lesopitron SCHEMBL246589 | 0.70 | HTR1A (0.52) | CYP2D6ALDH1A1 | |
| Lesopitron SCHEMBL1822413 | 0.69 | HTR1A (0.51) | KDM4EALDH1A1 | |
| Lesopitron SCHEMBL9201343 | 0.69 | HTR1A (0.51) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995028933-A1 | USE OF ARYLPIPERAZINE DERIVATIVES FOR THE TREATMENT OF PARKINSON'S DISEASE AND PSYCHOSIS | LABORATORIOS DEL DR. ESTEVE S.A. (ES) | 1995-11-02 | — | — | WO | disclosed |